Pfizer, Inc. vs Veeva Systems Inc. — Stock Comparison
Pfizer, Inc. (PFE) and Veeva Systems Inc. (VEEV) are both listed on US exchanges. This page compares their Q·Score ratings, key fundamentals (P/E, margins, growth), and Wall Street analyst consensus side by side. Data sourced from Yahoo Finance and updated on each page load.
Veeva Systems Inc. clearly outscores Pfizer, Inc. on Q·Score (8.8 vs 6.4 out of 10), led by Growth (8.6 vs 5.1) and Health (9.7 vs 7). Analyst consensus targets imply greater upside for VEEV (+60.1%) than for PFE (+15.8%).
Price Performance
Normalised to 100 at period start — shows relative performance.
Q·Score Breakdown
Forward P/E of 8.9× is low relative to sector peers.
⚠ earnings contracting 10% year-over-year.
Clean balance sheet with low leverage (0.0× debt-to-equity).
Analyst Consensus
Fundamentals
Frequently Asked Questions
PFE vs VEEV: which stock scores better overall?
Based on Q·Score, Veeva Systems Inc. (VEEV) scores 8.8/10 versus Pfizer, Inc. (PFE) at 6.4/10. The Q·Score measures five dimensions: Quality, Health, Growth, Valuation, and Sentiment. For informational purposes only — not financial advice.
Which has better revenue growth: PFE or VEEV?
Veeva Systems Inc. (VEEV) scores higher on Growth (8.6/10 vs 5.1/10). Pfizer, Inc. reports revenue growth (5.4% YoY) while Veeva Systems Inc. reports (16.3% YoY). Growth scores reflect revenue and earnings momentum relative to sector peers.
Is PFE or VEEV more attractively valued?
Veeva Systems Inc. (VEEV) scores higher on Valuation (9.1/10 vs 7.7/10). PFE trades at 8.9× P/E versus VEEV at 15.3×. Valuation is assessed using P/E ratio, analyst price targets, and 52-week range positioning relative to sector peers.
What do analysts say about PFE vs VEEV?
There are 27 analysts covering PFE with a consensus price target of $29.19, and 27 analysts covering VEEV with a consensus target of $245.48. Analyst consensus ratings are aggregated from Wall Street research and do not constitute investment advice.
Which is more profitable: PFE or VEEV?
Veeva Systems Inc. (VEEV) scores higher on Quality (8.8/10 vs 6.4/10). Net profit margin: PFE at 11.8%, VEEV at 28.4%. Quality scores reflect profit margins, return on equity, and free cash flow generation.
Which has stronger financial health: PFE or VEEV?
Veeva Systems Inc. (VEEV) scores higher on Financial Health (9.7/10 vs 7/10). Market beta: PFE at 0.29, VEEV at 0.95. Health scores consider beta, debt-to-equity, and current ratio. All investments carry risk — this is not investment advice.
What are the market caps of PFE and VEEV?
Pfizer, Inc. (PFE) has a market capitalisation of $143.7B, while Veeva Systems Inc. (VEEV) has a market cap of $24.9B. Market cap data is sourced from Yahoo Finance and reflects the most recent available figures.
Do PFE or VEEV pay dividends?
PFE pays a dividend yield of 6.61%, while VEEV does not currently pay a dividend. Dividend yields fluctuate with share price and company payout decisions.
Related Comparisons
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →